PTGX Dec 2024 15.000 call
| Previous close | 8.05 |
| Open | N/A |
| Bid | 9.90 |
| Ask | 12.80 |
| Strike | 15.00 |
| Expiry date | 2024-12-20 |
| Day's range | 8.05 - 8.05 |
| Contract range | N/A |
| Volume | |
| Open interest | 20 |
Investor's Business DailyProtagonist Therapeutics Surges On Plans To Join S&P SmallCap 600
Protagonist Therapeutics is poised to join the S&P SmallCap 600 next Wednesday, replacing copper and aluminum wire manufacturer Encore Wire.
PR NewswireProtagonist Therapeutics Set to Join S&P SmallCap 600
Protagonist Therapeutics Inc. (NASD: PTGX) will replace Encore Wire Corp. (NASD: WIRE) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, July 3. S&P Europe 350 constituent Prysmian SpA (MTAA: PRY) is acquiring Encore Wire in a deal expected to be completed soon pending final conditions.
Insider MonkeyIs Protagonist Therapeutics, Inc. (PTGX) a Good Healthcare Stock to Buy?
We recently compiled a list of the 10 Best Healthcare Stocks to Buy Under $50. In this article, we are going to take a look at where Protagonist Therapeutics, Inc. (NASDAQ:PTGX) stands against the other healthcare stocks under $50. If interested, you can also read our recent article on the 10 Best Healthcare Stocks To […]
